Lexaria Bioscience Corp. Annual report pursuant to Section 13 and 15(d)

Segment Information (Details 1) - USD ($)	Aug. 31, 2023	Aug. 31, 2022
Net Balance	$ 254,143	$ 315,505
Canada [Member]
Cost	193,185	548,256
Addition	0	6,817
Net Balance	131,288	215,474
US [Member]
Cost	140,490	98,050
Addition	33,748	42,375
Net Balance	122,855	100,031
Leasehold Improvements [Member]
Net Balance	11,258	65,296
Leasehold Improvements [Member] \| Canada [Member]
Cost	259,981	259,981
Addition	0	0
Net Balance	11,258	65,296
Leasehold Improvements [Member] \| US [Member]
Cost	0	0
Addition	0	0
Net Balance	0	0
Furniture Fixtures Equipment [Member]
Net Balance	1,869	8,288
Furniture Fixtures Equipment [Member] \| Canada [Member]
Cost	31,126	31,126
Addition	0	0
Net Balance	1,869	8,288
Furniture Fixtures Equipment [Member] \| US [Member]
Cost	0	0
Addition	0	0
Net Balance	0	0
Lab Equipment [Member]
Net Balance	236,391	232,564
Lab Equipment [Member] \| Canada [Member]
Cost	193,185	193,185
Addition	0	0
Net Balance	113,536	132,533
Lab Equipment [Member] \| US [Member]
Cost	140,487	98,050
Addition	33,748	42,375
Net Balance	122,855	100,031
Computer Equipment [Member]
Net Balance	4,625	9,357
Computer Equipment [Member] \| Canada [Member]
Cost	70,781	63,964
Addition	0	6,817
Net Balance	4,625	9,357
Computer Equipment [Member] \| US [Member]
Cost	0	0
Addition	0	0
Net Balance	$ 0	$ 0